Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 385
- Locations
- 1
- Primary Endpoint
- Diabetes Knowledge Score(DKQ-24)
Study Overview
Brief Summary
This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes. Participants in this study will attend pharmacist-led educational sessions designed to improve their understanding of diabetes and self-care practices. Researchers will assess changes in patients' knowledge, self-management behaviors, and clinical health markers before and after the intervention. The study will compare pre- and post-intervention results to determine the effectiveness of pharmacist-led education in transforming diabetes care.
Detailed Description
The purpose of this study is to investigate whether pharmacist-led education can enhance the knowledge, self-management behaviors, and health outcomes of diabetic patients. Effective diabetes management requires a comprehensive understanding of the disease, adherence to lifestyle modifications, and consistent monitoring of health indicators. Poor knowledge and suboptimal self-care can lead to inadequate glycemic control, complications, and reduced quality of life. This study will evaluate the impact of pharmacist-led educational interventions on patients' motivation, diabetes-related knowledge, and self-care behaviors, as well as their effects on clinical outcomes, including improved HbA1c levels, reduced hypo- and hyperglycemic episodes, and enhanced patient satisfaction. By addressing these critical aspects, the study aims to highlight the transformative role of pharmacist-led education in advancing diabetes care and fostering sustainable, patient-centered healthcare practices.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Supportive Care
- Masking
- None
Masking Description
Participants will be entertained as part of their regular appointment for prescription filling without any information of which group they are assigned in.
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •We will include all confirmed diabetic patients who visit the SIH endocrinology OPD Clinic during the study duration.
- •Both male and female patients visiting the Endocrinology Unit of the hospital will be eligible.
- •Patients with HbA1c levels greater than 8% will be included.
- •Both follow-up and newly diagnosed patients will be considered.
- •Patients who sign the informed consent form will be enrolled in the study.
Exclusion Criteria
- •We will exclude patients with gestational diabetes mellitus (GDM).
- •Patients with central obesity will not be included in the study.
- •Type 1 diabetes mellitus (DM) patients under the age of 20 will be excluded.
- •Patients with inadequate medical history will be excluded from participation.
- •Patients with HbA1c levels less than 8% will not be included.
- •Patients who do not provide informed consent or express a lack of interest in the study will be excluded.
Arms & Interventions
Interventional Group
Lifestyle Modifications: Education on healthy meal choices and physical activity to support diabetes management. Disease Education: In-depth information on diabetes, blood sugar control, and the prevention of complications. Self-Management Tools: Provision of blood glucose monitoring charts and practical strategies for daily diabetes care. Counseling: Personalized counseling to address emotional aspects, stress management, and confidence in managing diabetes.
Intervention: Pharmacist led Education (Behavioral)
Outcomes
Primary Outcomes
Diabetes Knowledge Score(DKQ-24)
Time Frame: 3 months
Patient's diabetes knowledge will be assessed using the Diabetes Knowledge Questionnaire (DKQ). The DKQ is a tool used to evaluate a patient's understanding of diabetes, including aspects such as blood sugar control, diet, exercise, and medication management. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score indicates a better level of knowledge regarding diabetes management.
Diabetes Management Self-Efficacy Score (DMSQ-16)
Time Frame: 3 months
Patient's diabetes self-management will be assessed using the Diabetes Self-Management Questionnaire (DMSQ). The DMSQ is a tool used to evaluate a patient's ability to manage their diabetes through self-care practices, including diet, physical activity, blood sugar monitoring, and medication adherence. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score reflects better self-management behaviors in managing diabetes.
HbA1C Levels (%)
Time Frame: 3 months
Patient's health outcomes will be assessed using HbA1c levels. HbA1c (glycated hemoglobin) is a blood test used to measure a patient's average blood sugar level over the past 3 months. It is a key indicator of diabetes management and glycemic control. The HbA1c level is reported as a percentage, with lower percentages indicating better control of blood sugar. A target HbA1c level of less than 7% is typically recommended for most diabetic patients. The score can range from high percentages (indicating poor control) to lower percentages (indicating better glycemic control).
Secondary Outcomes
No secondary outcomes reported
Investigators
SARA YAHYA
Principal Pharmacist
Shifa International Hospital